Gsa Capital Partners LLP Amneal Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 72,101 shares of AMRX stock, worth $612,858. This represents 0.04% of its overall portfolio holdings.
Number of Shares
72,101
Previous 54,350
32.66%
Holding current value
$612,858
Previous $452,000
26.33%
% of portfolio
0.04%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$126 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$105 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$95.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$91.1 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$76.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.29B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...